Loading...
Molecular targets for therapy in systemic sclerosis
Despite significant advances have been made in the recent years regarding organ-specific therapies, there is no approved 'disease-modifying' antifibrotic drug for systemic sclerosis (SSc) available to date. Although non-selective immunosuppressive agents are routinely used to treat patient...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3368787/ https://ncbi.nlm.nih.gov/pubmed/23259845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1755-1536-5-S1-S19 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|